Plasma Fatty Acid Composition Was Associated with Apelin Gene Expression in Human Adipose Tissues

Background. Apelin is an adipokine with an intermediatory role in obesity and insulin resistance, which can be modified by dietary intake. Aims. In this study, we aimed to determine the association of the plasma fatty acid composition with apelin plasma concentration and gene expression in visceral (VAT) and subcutaneous (SAT) adipose tissues. Methods. In this cross-sectional study, we recruited 179 patients aged 19-75 years who were candidates for elective surgery. Through the surgery, SAT and VAT were collected to measure apelin gene expression. Anthropometric measurements, fasting blood samples, and dietary intakes were collected before surgery. Free fatty acids (FFAs) in fasting whole plasma were measured using gas chromatography with flame ionization detection. Linear regression models were used to estimate standardized β (STZ β ) showing the association of individual and total FFAs with apelin gene expression after adjustment for potential confounding variables. Results. In multivariable analysis, we observed a significant positive association of total plasma free fatty acids (FFAs) (STZ β = 0.241 , P = 0.006 ), saturated fatty acid (SFA) (STZ β = 0.336 , P < 0.001 ), and monounsaturated fatty acid (MUFA) (STZ β = 0.313 , P < 0.001 ) concentrations with apelin gene expression from VAT after controlling for age, sex, body mass index, homeostatic model assessment for insulin resistance (HOMA-IR), physical activity, and energy intake. In the SFA family, there was a direct association with plasma concentration of myristic acid (STZ β = 0.372 , P < 0.001 ), pentadecanoic acid ( STZ β = 0.252 , P = 0.002 ), and heptadecanoic acid (STZ β = 0.407 , P < 0.001 ) with apelin mRNA expression in VAT. There was no significant association between FFAs and apelin plasma concentration and SAT mRNA levels. Conclusions. In conclusion, circulating plasma FFAs, SFA, and MUFA had a positive association with apelin gene expression in VAT. It seems that plasma fatty acid composition may regulate apelin gene expression in VAT.

Functionally Relevant Differences in Plasma Fatty Acid Composition and Expression of Cytotoxic and Inhibitory NK Cell Receptors between Healthy Young and Healthy Elder Adults

(1) Background: In the healthy ageing, NK cell number is not modified; however, their spontaneous cytotoxicity decreases. We postulated that the age-dependent decline in metabolic activities might be responsible for this effect. (2) Methods: The fatty acid profile of 30 healthy young males (23 ± 4 years old, BMI 22.1 ± 1.3) and 30 older males (63 ± 5 years old, BMI 22.9 ± 2.5) donors were evaluated along with the expression of killing (KR) and inhibitory NK receptors (KIR) at basal level and after cultivation with fatty acids for 24 h. (3) Results: Significantly higher levels of oleic (p < 0.01), arachidonic (p < 0.001), lignoceric (p < 0.001), and nervonic acids (p < 0.0001) and significantly lower levels of docosapentaenoic and docosahexaenoic acids (p < 0.01) were found in elders as compared to young adults. At basal levels, significant (p < 0.005) differences in KR and KIR expression were encountered; 12/16 antigens. Treatment of cells with saturated fatty acids or arachidonic acid (AA) significantly enhanced KR expressions (p < 0.001). AA treatment decreased inhibitory KIR expression while docosahexaenoic, and eicosapentaenoic acid increased them. (4) Conclusions: Changes in fatty acids blood levels, and KR and KIR expression in NK cell, are age-dependent. Supplementation of NK cells with eicosapentaenoic or docosahexaenoic acid enhanced inhibitory KIR receptors’ expression which may improve their cell function.

346 Supplementing Ca salts of soybean oil to enhance carcass quality of beef cattle via metabolic imprinting events

This experiment evaluated the effects of supplementing Ca salts of soybean oil (CSSO) at 2 mo of age via creep-feeding, upon weaning at 6 months of age, or no CSSO supplementation on growth and carcass development of beef cattle. A total of 64 steers were enrolled in this study over 2 years (32 steers/year), with 4 phases per year: creep-feeding (d 0 to 60), pre-weaning (d 61 to 120), post-weaning (d 121 to 180) and feedlot (181 to slaughter). On d 0 steers were ranked by body weight (BW) and age (114 ± 2 kg; 66 ± 0.5 d) and randomly assigned, in a 2 x 2 factorial, to receive 80 g/steer daily (creep-feeding) or 150 g/steer daily (post-weaning) of CSSO. Non-supplemented steers (CON) were provided with equivalent saturated fat supplement. On d 0, 61, 120, 180, and 330 steers were evaluated for longissimus muscle depth, backfat thickness, and marbling via real time ultrasonography, blood was sampled for determination of plasma fatty acid composition, muscle samples were collected via needle biopsy, and BW was recorded. After the creep-feeding phase, CSSO steers had greater (P &lt; 0.01) plasma concentrations of linoleic, omega-6, and total PUFA compared with CON. Steers that received CSSO during the postweaning phase had greater (P &lt; 0.01) plasma concentrations of linoleic, omega·-6, and total FA compared with CON prior to feedlot entry. No treatment differences were detected for performance or body composition responses (P &gt; 0.25) during any phase. However, mRNA expression of adipogenic/lipogenic genes was greater (P &lt; 0.03) prior to slaughter (d 330) in muscle of steers that had received CSSO during the creep-feeding phase. Results from this experiment suggest that supplementing CSSO to nursing beef steers via creep feeding stimulated metabolic imprinting effects through enhanced adipogenic gene expression, however did not alter phenotypic variables.

Reduction in FSH Throughout the Menstrual Cycle After Omega-3 Fatty Acid Supplementation in Young Normal Weight but not Obese Women

Dietary fish oil restores ovarian function in subfertile rats, which is thought to be associated with decreased transcription of follicle-stimulating hormone (FSH) β-subunit. We have previously demonstrated a reduction in early follicular serum FSH levels in normal weight but not obese women after treatment with omega-3 polyunsaturated fatty acids (PUFA). Herein, we report the effect of supplementation with omega-3 PUFA on urinary reproductive hormones across the whole menstrual cycle. This interventional study included 17 eumenorrheic women, aged 24-41 years. One month of daily morning urine was collected before and after 1 month of omega-3 PUFA supplementation with 4 g of eicosapentaenoic acid and docosahexaenoic acid daily. Measurements included urinary FSH, luteinizing hormone (LH) and estrogen and progesterone metabolites, plasma fatty acid composition, and markers of endoplasmic reticulum stress. Compliance with dietary supplementation was verified by significantly reduced ratios of omega-6 to omega-3 PUFA for all subjects after treatment ( P < .01). After 1 month of omega-3 PUFA supplementation, urinary FSH was significantly decreased in normal weight, but not obese women, in both follicular and luteal phases (−28.4% and −12.6%, respectively, both P = .04). No significant changes were seen in LH or sex steroids for either weight group. The selective and specific decrease in FSH suggests that omega-3 PUFA supplementation merits further investigation in normal weight women with decreased fertility and/or diminished ovarian reserve.